Latest Proprietary Technology News

Page 15 of 18
Plenti Group Limited reported a stellar FY25 with a 126% surge in Cash NPAT to $13.8 million, driven by robust loan portfolio growth and operational efficiency. The fintech lender is targeting a $3 billion loan book by March 2026, leveraging technology and strategic partnerships.
Claire Turing
Claire Turing
21 May 2025
Plenti Group Limited reported a robust FY25 with a 126% jump in Cash NPAT to $13.8 million and a 19% increase in its loan portfolio to $2.5 billion, driven by technology enhancements and strategic partnerships.
Claire Turing
Claire Turing
21 May 2025
Plenti Group Limited has reported a remarkable turnaround with a $24.8 million profit for the year ended March 2025, reversing a loss from the previous year. The fintech lender also announced its upcoming Annual General Meeting and director nomination deadlines.
Claire Turing
Claire Turing
21 May 2025
Worley Limited has reaffirmed its FY25 financial outlook, targeting low double-digit EBITA growth and margins between 8-8.5%, supported by a robust $9.4 billion bookings pipeline and a strategic operational reorganisation.
Victor Sage
Victor Sage
20 May 2025
Australian Bond Exchange Holdings has completed a $683,180 private placement, issuing over 17 million shares to strengthen its financial position and support expansion and cost-cutting initiatives.
Claire Turing
Claire Turing
16 May 2025
Mesoblast has been granted a seven-year orphan-drug exclusivity by the FDA for its cell therapy Ryoncil, reinforcing its market position in treating steroid-refractory acute graft versus host disease in children.
Ada Torres
Ada Torres
15 May 2025
Australian Bond Exchange Holdings (ASX: ABE) announces the resignation of director Anthony Hartman and the appointment of Robert Shaw and Mark O’Leary to its board, signaling a strategic boost in expertise.
Claire Turing
Claire Turing
8 May 2025
LTR Pharma has partnered with Strategic Drug Solutions to co-develop OROFLOW®, a novel intranasal spray aimed at providing fast symptom relief for Oesophageal Motility Disorders, tapping into a growing $4.5 billion global market.
Ada Torres
Ada Torres
8 May 2025
Computershare Limited reaffirmed its FY25 guidance at the Macquarie Australia Conference, projecting a 15% increase in management EPS supported by strong revenue growth and disciplined capital management.
Claire Turing
Claire Turing
6 May 2025
Vection Technologies has landed a $1.2 million grant to lead an innovative XR and AI digital twin project aimed at transforming real-time product intelligence in food and beverage manufacturing.
Sophie Babbage
Sophie Babbage
6 May 2025
Nanollose Limited has achieved a significant milestone by blending its Nullarbor-20™ sustainable fibre with Australian merino wool to produce pilot blankets, while also completing a $672,000 placement to fund ongoing commercialisation efforts.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Vectus Biosystems advances its lead fibrosis drug VB0004 with validated Phase I safety data and strategic cost reductions, while actively pursuing licensing partnerships in China.
Ada Torres
Ada Torres
30 Apr 2025